MARY VALENTINO: Open Payments
NPI 1790541548 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 52 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $226 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $205 |
| UROGEN PHARMA, INC. | 9 | $183 |
| Sumitomo Pharma America, Inc. | 8 | $171 |
| Astellas Pharma US Inc | 4 | $103 |
| TOLMAR, INC. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Boston Scientific Corporation | 3 | $77 |
| COLOPLAST CORP | 3 | $63 |
| ABBVIE INC. | 2 | $49 |
| ACCORD HEALTHCARE, INC. | 2 | $49 |
Products named: KEYTRUDA, JELMYTO, Xtandi, JATENZO, GEMTESA, ORGOVYX, Nubeqa, Luja Coude.
Industry payments across CT — which companies pay providers there.
